Epidural steroid injections (ESIs) may help reduce inflammation and provide short-term relief from disc-related back pain, but they do not repair the underlying annular tear. Biologic annular tear repair — specifically intra-annular fibrin injection — aims to seal and stabilize the disc itself. Whether one approach or the other is appropriate depends on each patient’s individual diagnosis, history, and goals.

For many people living with chronic back pain, the frustration is not just the pain itself — it is the cycle of temporary relief followed by recurring symptoms. Among the most widely used interventions are epidural steroid injections. While these can offer short-term respite, a regenerative approach known as biologic annular tear repair, performed as an intra-annular fibrin injection, is gaining attention as a potential path toward longer-term disc stabilization. This article examines how these two treatments differ in mechanism, durability, and clinical application — so you can have a more informed conversation with your care team.

Understanding the Root Cause: Annular Tears and Disc Degeneration

Before comparing treatments, it helps to understand what is driving the pain in many chronic back pain patients: damage to the intervertebral discs. These discs sit between the vertebrae and act as shock absorbers. Each disc has a tough outer shell called the annulus fibrosus and a gel-like inner core called the nucleus pulposus.

Over time — due to injury, age, or repetitive loading — the annulus fibrosus can develop tears. Because the annulus contains nerve endings, these tears can be a direct source of pain. They can also allow the inner nucleus material to leak outward, causing inflammation that irritates nearby nerve roots and may trigger radiating leg pain (sciatica), numbness, or weakness. An unsealed annular tear may also accelerate disc degeneration as the disc loses internal pressure and hydration.

Diagnostic imaging reports often use terms like “degenerative disc disease,” which can encompass annular tears, disc bulges, and herniations. Addressing the structural source of pain — rather than only suppressing the inflammatory response — is the central distinction between the two approaches discussed here. For a deeper overview of conditions that begin in the lumbar spine, see our resource on annular tears as a root cause of back pain.

Epidural Steroid Injections: Symptom Management Without Structural Repair

What Are Epidural Steroid Injections?

Epidural steroid injections involve delivering a corticosteroid — and often a local anesthetic — into the epidural space surrounding the spinal cord. The primary goal is to reduce inflammation and calm irritated nerve roots, particularly when a herniated disc or disc tear is producing significant radicular symptoms.

How Do They Work?

The corticosteroid component reduces swelling and dampens the chemical irritation affecting nearby nerves. The anesthetic component may provide more immediate, though short-lived, pain reduction. In select cases, this window of reduced pain may allow a patient to engage more effectively in physical therapy or other rehabilitative activities.

Limitations of Epidural Steroid Injections for Long-Term Relief

ESIs are recognized as a useful short-term management tool, but their long-term utility for chronic discogenic pain has significant limitations:

• Symptom masking, not structural repair: The annular tear remains unsealed after an injection. The disc continues to leak inflammatory material, and degeneration may progress.
• Temporary duration of effect: In many patients, relief lasts weeks to a few months. When the steroid wears off, pain frequently returns — often leading to repeated injection cycles without resolution.
• Risks associated with repeated injections: Potential complications include infection, bleeding, nerve injury, and systemic corticosteroid effects such as reduced bone density and elevated blood glucose. Most clinicians limit the number of injections a patient can receive within a given period.
• Limited evidence for chronic low back pain: Multiple systematic reviews have questioned the long-term benefit of ESIs for chronic low back pain originating from structural disc pathology.

In summary, epidural steroid injections are a reactive, symptom-focused intervention. They do not repair disc tissue or promote regeneration. For patients whose pain stems from a structural annular defect, repeated ESIs may provide diminishing returns over time. Candidates are always evaluated individually to determine whether continued injection therapy or an alternative approach is more appropriate for their specific situation.

Expert Take

Epidural steroid injections remain appropriate in selected clinical contexts — particularly for managing acute radicular flares or bridging patients toward rehabilitation. However, when imaging-confirmed annular tears are the primary driver of chronic pain and multiple injections have failed to produce lasting benefit, it is worth evaluating whether a structural repair approach may be more suitable. Every case requires individual assessment.

Biologic Annular Tear Repair: A Regenerative Approach to Disc Healing

What Is Biologic Annular Tear Repair?

Biologic annular tear repair — performed as an intra-annular fibrin injection — represents a structurally different philosophy in spine care. Rather than suppressing the inflammatory response downstream of a disc tear, fibrin disc treatment targets the tear itself. This minimally invasive, outpatient procedure involves injecting a fibrin biologic directly into the torn outer layers of the intervertebral disc under fluoroscopic (X-ray) guidance.

How Does Fibrin Disc Treatment Work?

Fibrin is a natural protein that plays a central role in wound healing and tissue repair. When delivered precisely into an annular defect, it may achieve several clinically meaningful effects:

• Sealing the tear: The fibrin biologic acts as a biological scaffold that may close the defect in the annulus, reducing or stopping the leakage of nucleus material into the spinal canal.
• Supporting the healing environment: By creating a structural matrix within the tear, fibrin may facilitate migration of the body’s own reparative cells — such as fibroblasts — into the injured area, potentially encouraging growth of new connective tissue.
• Preserving disc mechanics: Sealing the annular defect and containing the nucleus pulposus may help restore internal disc pressure dynamics, potentially slowing further height loss and degeneration.
• Reducing inflammatory leakage: By limiting the outflow of pro-inflammatory nucleus material into the spinal canal, the procedure may directly address a key source of nerve irritation and discogenic pain.

Patients are typically able to return home the same day. Recovery timelines vary by individual, and our clinical team works with each patient to set appropriate expectations based on their specific disc pathology and overall health status. For additional detail on what the repair process involves, see our overview of annular tear repair as a non-surgical approach.

Comparing Long-Term Outcomes: What the Evidence Suggests

When evaluating interventions for chronic disc-related pain, durability of effect is a critical measure. Here is how these two approaches compare on that dimension:

Fibrin Disc Treatment: Emerging Long-Term Data

Clinical studies on intra-annular fibrin injection for chronic discogenic back pain have shown encouraging results in appropriately selected patients:

• Published data indicate meaningful reductions in pain scores over follow-up periods extending beyond two years in many patients who underwent the procedure, with outcomes varying by individual case.
• A substantial proportion of patients in reported cohorts described improved quality of life and ability to return to daily activities at the two-year follow-up mark — though individual results vary and not every patient achieves the same degree of improvement.
• Among patients who had previously undergone back surgery and experienced persistent or recurrent symptoms, fibrin disc treatment has shown positive outcomes in a meaningful subset — highlighting its potential role as an option for those who have not found relief through prior interventions. For more on this topic, see our article on biologic disc repair after failed back surgery.
• Follow-up imaging in some patients has demonstrated evidence of annular stabilization and tear closure, suggesting structural improvement rather than purely symptomatic suppression — though imaging findings vary by case.

Epidural Steroid Injections: Long-Term Structural Limitations

The primary limitation of ESIs in the context of chronic discogenic pain is the absence of any mechanism for structural repair. Key long-term concerns include:

• Pain often recurs as the steroid effect diminishes, typically within weeks to months.
• Repeated injections carry cumulative risk and do not prevent continued disc degeneration.
• Patients who rely on repeated ESIs without addressing the structural deficit may ultimately progress to more severe disc disease that may eventually require surgical consideration.

The core distinction is this: ESIs aim to quiet an inflammatory response that is a consequence of disc structural failure, while fibrin disc treatment aims to address the structural failure itself. Whether either or both are appropriate for a given patient depends on individual evaluation. You can explore additional comparisons in our overview of moving beyond epidural injections toward fibrin disc treatment.

Who May Be a Candidate for Biologic Annular Tear Repair?

Fibrin disc treatment is a specialized procedure, and candidates are evaluated individually. Not everyone with back pain will qualify. Patients who are commonly considered for evaluation include those who:

• Have chronic low back pain — or in some cases neck pain — primarily attributed to an identifiable annular tear or degenerative disc disease confirmed on MRI.
• Have worked through conservative care options such as physical therapy, chiropractic treatment, and oral medications without achieving meaningful or lasting relief.
• Have diagnostic imaging that clearly demonstrates annular pathology correlating with their reported pain pattern.
• Are seeking a non-surgical alternative to spinal fusion or other more invasive procedures.
• Have not experienced lasting relief from epidural steroid injections or other minimally invasive symptom-management approaches.

A thorough evaluation — including a detailed review of medical history, physical examination, and imaging — is essential before any treatment decision is made. Our clinical team assesses each patient individually to determine whether biologic disc repair is an appropriate option for their specific situation. Learn more about what determines eligibility in our guide on candidacy for biologic disc repair.

A Structural vs. Symptomatic Framework for Chronic Disc Pain

At Valor Spine, our clinical team approaches chronic discogenic pain with a focus on identifying and, where possible, addressing the structural source of a patient’s symptoms — rather than relying indefinitely on interventions that manage those symptoms without changing the underlying disc condition. We recognize that both epidural steroid injections and biologic annular tear repair have legitimate roles in a comprehensive spine care plan, and that the right path forward is different for each patient.

If you have experienced repeated cycles of temporary relief from injections and are interested in learning whether a regenerative, structure-focused approach may be appropriate for your condition, we encourage you to explore your options further. Our team specializes in evaluating patients who have not found lasting solutions through conventional care — including those who have been told surgery is their only remaining option.

For further reading, we recommend: Beyond Failed Epidurals: Intra-Annular Fibrin Injection for Persistent Back Pain